OBJECTIVE: This was a systematic review and meta-analysis to determine the proportion of Escherichia coli O157 cases that develop chronic sequelae. DATA SOURCES: We conducted a systematic review of articles published prior to July 2011 in Pubmed, Agricola, CabDirect, or Food Safety and Technology Abstracts. STUDY SELECTION: Studies were selected that reported the number of E. coli O157 cases that developed reactive arthritis (ReA), hemolytic uremic syndrome (HUS), irritable bowel syndrome, inflammatory bowel disease, or Guillain Barré syndrome. METHODS: Three levels of screening and data extraction of articles were conducted using predefined data fields. Meta-analysis was performed on unique outcome measures using a random-effects model, and heterogeneity was assessed using the I² value. Meta-regression was used to explore the influence of nine study-level variables on heterogeneity. RESULTS: A total of 82 studies were identified reporting 141 different outcome measures; 81 reported on HUS and one reported on ReA. Depending on the number of cases of E. coli O157, the estimate for the proportion of E. coli O157 cases that develop HUS ranged from 17.2% in extra-small studies (<50 cases) to 4.2% in extra-large studies (>1000 cases). Heterogeneity was significantly associated with group size (p<0.0001); however, the majority of the heterogeneity was unexplained. CONCLUSIONS: High unexplained heterogeneity indicated that the study-level factors examined had a minimal influence on the variation of estimates reported.
OBJECTIVE: This was a systematic review and meta-analysis to determine the proportion of Escherichia coli O157 cases that develop chronic sequelae. DATA SOURCES: We conducted a systematic review of articles published prior to July 2011 in Pubmed, Agricola, CabDirect, or Food Safety and Technology Abstracts. STUDY SELECTION: Studies were selected that reported the number of E. coli O157 cases that developed reactive arthritis (ReA), hemolytic uremic syndrome (HUS), irritable bowel syndrome, inflammatory bowel disease, or Guillain Barré syndrome. METHODS: Three levels of screening and data extraction of articles were conducted using predefined data fields. Meta-analysis was performed on unique outcome measures using a random-effects model, and heterogeneity was assessed using the I² value. Meta-regression was used to explore the influence of nine study-level variables on heterogeneity. RESULTS: A total of 82 studies were identified reporting 141 different outcome measures; 81 reported on HUS and one reported on ReA. Depending on the number of cases of E. coli O157, the estimate for the proportion of E. coli O157 cases that develop HUS ranged from 17.2% in extra-small studies (<50 cases) to 4.2% in extra-large studies (>1000 cases). Heterogeneity was significantly associated with group size (p<0.0001); however, the majority of the heterogeneity was unexplained. CONCLUSIONS: High unexplained heterogeneity indicated that the study-level factors examined had a minimal influence on the variation of estimates reported.
Authors: S Hamano; Y Nakanishi; T Nara; T Seki; T Ohtani; T Oishi; K Joh; T Oikawa; Y Muramatsu; Y Ogawa Journal: Acta Paediatr Date: 1993-05 Impact factor: 2.299
Authors: Amit X Garg; John Marshall; Marina Salvadori; Heather R Thiessen-Philbrook; Jennifer Macnab; Rita S Suri; R Brian Haynes; Janet Pope; William Clark Journal: J Clin Epidemiol Date: 2006-01-27 Impact factor: 6.437
Authors: L A King; A Mailles; P Mariani-Kurkdjian; C Vernozy-Rozand; M P Montet; F Grimont; N Pihier; H Devalk; F Perret; E Bingen; E Espié; V Vaillant Journal: Epidemiol Infect Date: 2008-10-23 Impact factor: 2.451
Authors: Kevin G J Pollock; Mary E Locking; T James Beattie; Heather Maxwell; Ian Ramage; David Hughes; Jennifer Cowieson; Lesley Allison; Mary Hanson; John M Cowden Journal: Emerg Infect Dis Date: 2010-05 Impact factor: 6.883
Authors: Yan D Niu; Hui Liu; Hechao Du; Ruiqiang Meng; El Sayed Mahmoud; Guihua Wang; Tim A McAllister; Kim Stanford Journal: Front Microbiol Date: 2021-02-24 Impact factor: 5.640
Authors: Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco Journal: Foodborne Pathog Dis Date: 2019-10-07 Impact factor: 3.788
Authors: M Kate Thomas; Regan Murray; Logan Flockhart; Katarina Pintar; Aamir Fazil; Andrea Nesbitt; Barbara Marshall; Joanne Tataryn; Frank Pollari Journal: Foodborne Pathog Dis Date: 2015-08-10 Impact factor: 3.171